Invest with Genome Capital
1
Expected Deals/Year
0
Unique LPs have invested
Note from Genome Capital
Dear Investors, we would like to present one of the fastest growing Telemedicine companies from emerging markets:
Traction
✅ The company is 1year old, 314 thousand customers served, 322 thousand downloads of the application
✅ ARR $16MM, Gross profit $2m, revenue growth +30% MoM over the last 10 months (month to month)
✅ 42% repeat customers
✅ 71% of clients are women and children
Fundraising
Seed round $3m at $40m post money valuation. Already received a commitments from early and new investors for 55% of the investment round. The rest of the round is still available.
The expected closing date of the round is the end of July 2022.
Round utilization
$1.3 M to finalize the application, add analytics, remote monitoring modules, AI.
$1.1 M for marketing expenses and expansion to other countries.
$0.6 M expenses for the labor of the operating and technical team.
Genome Capital offers investments in the world's leading companies and future unicorns. We pride ourselves on being honest and putting your financial goals first whether we are selling you equity or managing your investment portfolio. We give everything we have got to deliver you stellar investment returns. Genome Capital works primarily as a family office for ultra-high net worth individuals treating our clients and colleagues as a family with dignity and respect. Our global Team daily monitors financial markets to provide timely advice on the best investment opportunities to our Clients. Our Team consists of entrepreneurs and financial managers with over 100 successful investment transactions and over 1 billion dollars in transaction value as well as company-building experience with many successful exits.
